King Pharmaceuticals, Inc. and King Pharmaceuticals Research and Development, Inc. v. Sandoz Inc.

NOTE: This order is nonprecedential.

# United States Court of Appeals for the Federal Circuit

KING PHARMACEUTICALS, INC.
AND KING PHARMACEUTICALS RESEARCH AND
DEVELOPMENT, INC.,
Plaintiffs-Appellants,
AND
PHARMACEUTICAL IP HOLDING, INC.,
Plaintiff-Appellant,
V.
SANDOZ INC.,
Defendant-Appellee.

2011-1227

Appeal from the United States District Court for the
District of New Jersey in case no. 08-CV-5974, Chief
Judge Garrett E. Brown, Jr.

ON MOTION

ORDER
The appellants move to withdraw their appeal.
Upon consideration thereof,

<!-- PageBreak -->

<!-- PageHeader="KING PHARMA v. SANDOZ" -->

IT IS ORDERED THAT:

(1) The motion is granted. The appeal is dismissed.

(2) Each side shall bear its own costs.

FOR THE COURT

SEP 0 1 2011

/s/ Jan Horbaly

Date

Jan Horbaly Clerk

cc: F. Dominic Cerrito, Esq.
Michelle S. Rhyu, Esq.
Martin B. Pavane, Esq.

s21

Issued As A Mandate:

SEP 0 1 2011

FILED
U.S. COURT OF APPEALS FOR
THE FEDERAL CIRCUIT
SEP. 0 1 2011

JAN HORBALY
CLERK